Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomer Meirson

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|May 6, 2024
Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival timeItamar Averbuch, Assaf Moore, Ethan B Ludmir, et al.
European Journal of Cancer (Oxford, England : 1990)|June 29, 2021
Informative censoring of surrogate end-point data in phase 3 oncology trialsShai Gilboa, Yarden Pras, Aviv Mataraso, et al.
Bioinformatics (Oxford, England)|June 29, 2019
A helical lock and key model of polyproline II conformation with SH3Tomer Meirson, David Bomze, Liron Kahlon, et al.
Hepatobiliary Surgery and Nutrition|December 16, 2022
Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effectNir Horesh, David Bomze, Chetana Lim, et al.
NAR Cancer|January 23, 2023
Systemic structural analysis of alterations reveals a common structural basis of driver mutations in cancerTomer Meirson, David Bomze, Ora Schueler-Furman, et al.
Translational Neuroscience|June 8, 2018
Intracerebroventricular Administration of L-arginine Improves Spatial Memory Acquisition in Triple Transgenic Mice Via Reduction of Oxidative Stress and ApoptosisGennadiy Fonar, Baruh Polis, Tomer Meirson, et al.
Ocular Immunology and Inflammation|August 5, 2020
Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance AnalysisDavid Bomze, Tomer Meirson, Omar Hasan Ali, et al.
British Journal of Clinical Pharmacology|September 23, 2020
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reportsAdam Goldman, David Bomze, Rachel Dankner, et al.
Oncotarget|July 19, 2018
Oral inflammation promotes oral squamous cell carcinoma invasionCameron Goertzen, Hayder Mahdi, Catherine Laliberte, et al.
JAMA Network Open|October 23, 2020
Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint InhibitorsDavid Bomze, Nethanel Asher, Omar Hasan Ali, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|May 6, 2024
Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival timeItamar Averbuch, Assaf Moore, Ethan B Ludmir, et al.
European Journal of Cancer (Oxford, England : 1990)|June 29, 2021
Informative censoring of surrogate end-point data in phase 3 oncology trialsShai Gilboa, Yarden Pras, Aviv Mataraso, et al.
Bioinformatics (Oxford, England)|June 29, 2019
A helical lock and key model of polyproline II conformation with SH3Tomer Meirson, David Bomze, Liron Kahlon, et al.
Hepatobiliary Surgery and Nutrition|December 16, 2022
Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effectNir Horesh, David Bomze, Chetana Lim, et al.
NAR Cancer|January 23, 2023
Systemic structural analysis of alterations reveals a common structural basis of driver mutations in cancerTomer Meirson, David Bomze, Ora Schueler-Furman, et al.
Translational Neuroscience|June 8, 2018
Intracerebroventricular Administration of L-arginine Improves Spatial Memory Acquisition in Triple Transgenic Mice Via Reduction of Oxidative Stress and ApoptosisGennadiy Fonar, Baruh Polis, Tomer Meirson, et al.
Ocular Immunology and Inflammation|August 5, 2020
Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance AnalysisDavid Bomze, Tomer Meirson, Omar Hasan Ali, et al.
British Journal of Clinical Pharmacology|September 23, 2020
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reportsAdam Goldman, David Bomze, Rachel Dankner, et al.
Oncotarget|July 19, 2018
Oral inflammation promotes oral squamous cell carcinoma invasionCameron Goertzen, Hayder Mahdi, Catherine Laliberte, et al.
JAMA Network Open|October 23, 2020
Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint InhibitorsDavid Bomze, Nethanel Asher, Omar Hasan Ali, et al.
Pageof 6